Archive for September, 2010

Biotechnology and a Better World by Design

I will be moderating a panel on the roles of biotechnology in development at the upcoming A Better World by Design conference at Brown University. The theme of the panel will be the promise and challenges of implementing biotechnology advances for public benefit, with a focus on topics such as disease prevention, agricultural improvements, and […]


Medicine for Tomorrow: An Article on Pharmaceutical Research and Development by Nobel Prize-Winning Economist Joseph Stiglitz

As stringent new budgets have led to pharmaceutical companies cutting back, a certain concern and scepticism has risen over the high prices charged by drug companies, their continued problems with productivity, and falling success rates of new drugs. A significant drop in investment in drugmaking companies, and president Obama’s recent reforms of the healthcare system […]


New reports from DrugPatentWatch

New Reports Based on Data-Mining the DrugPatentWatch database Please contact us with any special data requirements beyond the existing report catalog Orphan Drug Report The Orphan Drug Report profiles pharmaceutical drugs with FDA Orphan Drug Exclusivity The Report includes: The tradename, applicant, ingredient, and Orphan exclusivity expiration dates for each Orphan Drug Details on each […]


New Book – Biotechnology Entrepreneurship: From Science to Solutions

I’ve just published a new book, by Michael L. Salgaller, PhD. In Biotechnology Entrepreneurship: From Science to Solutions Michael combines the voices of a diverse set of industry insiders with extensive experience in biotechnology commercialization to prepares nascent founders, managers, investors, and other biotechnology company stakeholders to position themselves and their companies for commercial success. […]


Biotechnology and a Better World by Design

I will be moderating a panel on the roles of biotechnology in development at the upcoming A Better World by Design conference at Brown University. The theme of the panel will be the promise and challenges of implementing biotechnology advances for public benefit, with a focus on topics such as disease prevention, agricultural improvements, and […]


Kraig Biocraft Laboratories, Inc. Announces That It Has Successfully Created Transgenic Silkworm

Kraig Biocraft Laboratories, Inc. (OTC.BB:KBLB), a biotechnology company focused on the development of commercially significant high performance polymers including spider silk, today confirmed that scientists working in collaboration with the Company have successfully created transgenic silkworms. The silkworms were successfully genetically engineered with targeted spider silk DNA sequences. “We are very excited to be able […]


Drug Patent Challenge Report

I’ve posted a new Drug Patent Challenge Report at thinkPharm.com. This new report complements the Drug Patent Inventor Report and Orphan Drug Report and profiles the companies that successfully challenged pharmaceutical drug patents. The Drug Patent Challenge Report includes: A list of the companies with the most successful patent challenges A list of all the […]